Shares of Catalyst Pharmaceuticals rose 5.54% to $3.53 at 15:41 EST on Monday, following last session’s downward trend. NASDAQ Composite is dropping 1.7% to $12,669.76, after two consecutive sessions in a row of gains. This seems, up to now, an all-around negative trend exchanging session today.

Catalyst Pharmaceuticals’s last close was $3.34, 49.79% under its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 11.6% for the ongoing quarter and 4.6% for the next. The company’s growth estimates for the ongoing quarter is 25% and a drop 10% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Volatility

Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was a negative 2.40%, a negative 0.48%, and a negative 0.28%, respectively.

Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 3.94%, 3.82%, and 4.84%, respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $3.53 at 15:41 EST, way below its 52-week high of $5.28 and way above its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is higher than its 50-day moving average of $3.52 and under its 200-day moving average of $3.70.

LEAVE A REPLY

Please enter your comment!
Please enter your name here